BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24989996)

  • 1. Selenoprotein P as a diabetes-associated hepatokine that impairs angiogenesis by inducing VEGF resistance in vascular endothelial cells.
    Ishikura K; Misu H; Kumazaki M; Takayama H; Matsuzawa-Nagata N; Tajima N; Chikamoto K; Lan F; Ando H; Ota T; Sakurai M; Takeshita Y; Kato K; Fujimura A; Miyamoto K; Saito Y; Kameo S; Okamoto Y; Takuwa Y; Takahashi K; Kidoya H; Takakura N; Kaneko S; Takamura T
    Diabetologia; 2014 Sep; 57(9):1968-76. PubMed ID: 24989996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin suppresses expression of the selenoprotein P gene via an AMP-activated kinase (AMPK)/FoxO3a pathway in H4IIEC3 hepatocytes.
    Takayama H; Misu H; Iwama H; Chikamoto K; Saito Y; Murao K; Teraguchi A; Lan F; Kikuchi A; Saito R; Tajima N; Shirasaki T; Matsugo S; Miyamoto K; Kaneko S; Takamura T
    J Biol Chem; 2014 Jan; 289(1):335-45. PubMed ID: 24257750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
    Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
    Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A liver-derived secretory protein, selenoprotein P, causes insulin resistance.
    Misu H; Takamura T; Takayama H; Hayashi H; Matsuzawa-Nagata N; Kurita S; Ishikura K; Ando H; Takeshita Y; Ota T; Sakurai M; Yamashita T; Mizukoshi E; Yamashita T; Honda M; Miyamoto K; Kubota T; Kubota N; Kadowaki T; Kim HJ; Lee IK; Minokoshi Y; Saito Y; Takahashi K; Yamada Y; Takakura N; Kaneko S
    Cell Metab; 2010 Nov; 12(5):483-95. PubMed ID: 21035759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous Selenoprotein P, a Liver-Derived Secretory Protein, Mediates Myocardial Ischemia/Reperfusion Injury in Mice.
    Chadani H; Usui S; Inoue O; Kusayama T; Takashima SI; Kato T; Murai H; Furusho H; Nomura A; Misu H; Takamura T; Kaneko S; Takamura M
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29547524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Phosphotyrosine Phosphatase 1B (PTP1B) in Calpain-dependent Feedback Regulation of Vascular Endothelial Growth Factor Receptor (VEGFR2) in Endothelial Cells: IMPLICATIONS IN VEGF-DEPENDENT ANGIOGENESIS AND DIABETIC WOUND HEALING.
    Zhang Y; Li Q; Youn JY; Cai H
    J Biol Chem; 2017 Jan; 292(2):407-416. PubMed ID: 27872190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatokine Selenoprotein P-Mediated Reductive Stress Causes Resistance to Intracellular Signal Transduction.
    Takamura T
    Antioxid Redox Signal; 2020 Sep; 33(7):517-524. PubMed ID: 32295394
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperbaric oxygen potentiates diabetic wound healing by promoting fibroblast cell proliferation and endothelial cell angiogenesis.
    Huang X; Liang P; Jiang B; Zhang P; Yu W; Duan M; Guo L; Cui X; Huang M; Huang X
    Life Sci; 2020 Oct; 259():118246. PubMed ID: 32791151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of AT2 Receptor Prevents SHP-1-Induced VEGF Inhibition and Improves Blood Flow Reperfusion in Diabetic Ischemic Hindlimb.
    Paquin-Veillette J; Lizotte F; Robillard S; BĂ©land R; Breton MA; Guay A; Despatis MA; Geraldes P
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2291-2300. PubMed ID: 29074590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating selenoprotein P levels predict glucose-lowering and insulinotropic effects of metformin, but not alogliptin: A post-hoc analysis.
    Takeshita Y; Tanaka T; Takayama H; Kita Y; Goto H; Nakano Y; Saito Y; Takamura T
    J Diabetes Investig; 2023 Feb; 14(2):230-235. PubMed ID: 36479595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTP1b is a physiologic regulator of vascular endothelial growth factor signaling in endothelial cells.
    Lanahan AA; Lech D; Dubrac A; Zhang J; Zhuang ZW; Eichmann A; Simons M
    Circulation; 2014 Sep; 130(11):902-9. PubMed ID: 24982127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RasGRP1 is a target for VEGF to induce angiogenesis and involved in the endothelial-protective effects of metformin under high glucose in HUVECs.
    Xu J; Liu M; Yu M; Shen J; Zhou J; Hu J; Zhou Y; Zhang W
    IUBMB Life; 2019 Sep; 71(9):1391-1400. PubMed ID: 31120617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
    Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
    Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between selenoprotein P and glucose metabolism in experimental studies.
    Mao J; Teng W
    Nutrients; 2013 May; 5(6):1937-48. PubMed ID: 23760059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
    Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of hepatokines involved in pathology of type 2 diabetes and obesity.
    Misu H
    Endocr J; 2019 Aug; 66(8):659-662. PubMed ID: 31366824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
    Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis.
    Tawa H; Rikitake Y; Takahashi M; Amano H; Miyata M; Satomi-Kobayashi S; Kinugasa M; Nagamatsu Y; Majima T; Ogita H; Miyoshi J; Hirata K; Takai Y
    Circ Res; 2010 Jun; 106(11):1731-42. PubMed ID: 20413783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.